References
- Moore J G, Englert E. Circadian rhythm of gastric acid secretion in man. Nature 1970; 226: 1261–2
- Sanders S W, Moore J G, Buchi K N, Bishop A L. Circadian variation in the pharmacodynamic effect of intravenous ranitidine. Annual review ofchrono-pharmacology, A Reinberg, M Smolensky, G Labrecque. Pergamon, OxfordEngland 1988; Vol 5: 335–8
- Ballesteros M A, Hogan D L, Koss M A, Isenberg J I. Bolus or intravenous infusions of ranitidine: effects on gastric pH and acid secretion. Ann Intern Med 1990; 112: 334–9
- Halberg F, Halberg E. Appendix: terms for methods and facts in chronopharmacology. Toward chronopharmacology, R Takahashi, F Halberg, C A Walker. Pergamon, OxfordEngland 1982; 391–423
- Gibaldi M, Perrier D. Pharmacokinetics, 2nd ed. Marcel Dekker, New York 1982
- Echizen H, Shoda R, Umida N, Ishizaki T. Plasma famotidine concentrations versus intragastric pH in patients with upper gastrointestinal bleeding and in healthy subjects. Clin Pharmacol Ther 1988; 44: 690–8
- Holford N HG, Sheiner L B. Understanding the dose-effect relationship. Clin Pharmacokinet 1981; 6: 429–53
- Sanders S W, Ballesteros M A, Hogan D L, Koss M A, Isenberg J I. Effect of basal acid secretion on the pharmacodynamics of ranitidine. Chronobiol Int 1991; 8: 186–93
- Sanders S W, Buchi K N, Bishop A L, Moore J G. Pharmacodynamics of intravenous ranitidine after bolus and continuous infusion in patients with healed duodenal ulcers. Clin Pharmacol Ther 1989; 46: 545–51
- Ostro M J. Pharmacodynamics and pharmacokinetics of parenteral histmine (H2)-receptor antagonists. Am J Med 1987; 83(suppl 6A)15–22
- Merki H S, Witzel L, Kaufman K, et al. Continuous intravenous infusions of famotodine maintain high intragastric pH in duodenal ulcer. Gut 1988; 29: 453–7
- Wilder-Smith C H, Ernst T, Gennoni M, Zeyer B, Halter F, Merki H S. Tolerance to oral H2-receptor antagonists. Dig Dis Sci 1990; 35: 976–83